Epidemiology of sarcoidosis;Epidemiología de la sarcoidosis

Archivos de Bronconeumologia

Volumn 43, Issue 2, 2007, Pages 92-100

  Fernández Fabrellas, Estrella ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Epidemiology; Etiology; Sarcoidosis

Indexed keywords

GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNE RESPONSE; INCIDENCE; LUNG FUNCTION; MORTALITY; PREVALENCE; REVIEW; RISK FACTOR; SARCOIDOSIS; SEX DIFFERENCE;

EID: 33847744704     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13098420     Document Type: Review

References (68)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (WASOG) adopted by the ATS Board Directors and by the ERS Executive Committee. Am J Respir Crit Care Med. 1999;160:736-55.
2. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234-41.
3. Rossman MD, Thompson BW, Frederik M, Cizman B, Magira E, Monos D. Association of HLA class II alleles with sarcoidosis: results by race and sex of the ACCESS study. Am J Respir Crit Care Med. 2001;163:A959.
4. Du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med. 2003;253:4-17.
5. Yamamoto M, Sharma OP, Hosoda Y. Special report: the 1991 descriptive definition of sarcoidosis. Sarcoidosis. 1992;9 Suppl 1:33-4.
6. Newman LS. Aetiologies of sarcoidosis. Eur Respir Mon. 2005;32:23-48.
7. Henke CE, Henke G, Elveback R, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986;123:840-5.
8. Alcoba Leza M, Pérez-Simón MR, Guerra Laso JM, Carro Fernández JA, Alonso Fernández MA, Blanco Iglesias B, et al. Sarcoidosis en un área sanitaria de León. Epidemiología y características clínicas. An Med Interna. 2003;20:617-20.
9. Mana J, Badrinas F, Morera J, Fite E, Manresa F, Fernández-Nogues F. Sarcoidosis in Spain. Sarcoidosis. 1992;9:118-22.
10. Xaubet A, Ancochea J, Morell F, Rodríguez-Arias JM, Villena V, Blanquer R, et al. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:64-70.
11. Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis. En: Sharma OMP, editor. Clinics in chest medicine: sarcoidosis. Philadelphia: W.B. Saunders Company; 1997. p. 681-94.
12. ACCESS Research Group. Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS). J Clin Epidemiol. 1999;52:12:1173-86.
13. Terstein AS, Judson MA, Baughman RP, Rossman MD, Yeager H, Moller DR, et al. The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:139-46.
14. Freemer M, King TE. The ACCESS Study. Characterization of sarcoidosis in the United States. Am J Respir Crit Care Med. 2001;164:1754-5.
15. Yeager H, Rossman MD, Baughman RP, Teirstein AS, Judson MA, Rabin DL, et al. Pulmonary and psychosocial findings at enrollment in ACCESS study. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:147-53.
16. Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD, et al. Two years prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Dis. 2003;20:204-11.
17. Baughman R, Teirstein A, Judson M, Rossman MD, Yeager H, Bresnitz EA, et al. Clinical characteristics of patients in A Case Control Study of Sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-9.
18. Keller AZ. Anatomic sites, age attributes and rates of sarcoidosis in U.S. veterans. Am Rev Respir Dis. 1973;107:615-20.
19. Rybicki BA, Maliarik MJ, Major M, Popovich J, Iannuzzi MC. Epidemiology, demographics and genetics of sarcoidosis. Semin Respir Infect. 1998;13:166-73.
20. Chapelon-Abric C. Epidemiology of sarcoidosis and its genetic and environmental risk factors. Rev Med Intern. 2004;25:494-500.
21. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study compromising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:46-52.
22. Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004;93:30-6.
23. Rybicki BA, Iannuzzi MC, Frederik MM, Thompson BW, Rossman MD, Bresnitz EA, et al. Familial aggregation of sarcoidosis. A Case-Control Etiologic Study of Sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085-91.
24. Spagnolo P, Renzoni EA, Wells AU, Sato H, Grutters JC, Sestini P, et al. C-C chemokine receptor 2 and sarcoidosis: association with Löfgren's syndrome. Am J Respir Crit Care Med. 2003;168:1162-6.
25. Grunewald J, Wahlstrom J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with shared HLA-DR beta chain conformation. Thorax. 2002;57:348-52.
26. Badrinas F, MoreraJ, Fité E, Plasencia A. Seasonal clustering of sarcoidosis. Lancet. 1989;2:455-6.
27. Panayeas S, Theodorakopoulos P, Bouras A, Constantopoulos S. Seasonal occurrence of sarcoidosis in Greece. Lancet. 1991;338:510-1.
28. Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J. 1998;12:1197-9.
29. Newman LS, Rose CS, Bresnitz EA, Milton DR, Barnard J, Frederik M, et al. A case control etiologic study of sarcoidosis. Environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324-30.
30. Pérez Arellano JL, Ramos Guevara RM, López Ochoa FJ, Alcázar Montero MC, De León Gómez B, Flores MT, et al. Sarcoidosis. Estudio retrospectivo de 30 casos en Salamanca y comparación con otras series nacionales. Rev Clin Esp. 1991;189:159-62.
31. Hills SE, Parkes SA, Baker SBC. Epidemiology of sarcoidosis in the Isle of Man: evidence for space-time clustering. Thorax. 1987;42:427-30.
32. Chappell AG, Cheung WY, Hutchings HA. Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17:167-73.
33. Thomeer MJ, VansteenkisteJ, Verbeken EK, Demedts M. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med. 2004;98:567-73.
34. Sulica R, Teirstein AS, Kakarla S, Nemani N, Behnegar A, Padilla ML. Distinctive clinical, radiographic and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest. 2005;128:1483-9.
35. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med. 1999;160:1668-72.
36. Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J. 1998;12:906-12.
37. Foley PJ, Lympany PA, Puscinska E, Zielinski J, Welsh KI, Du Bois RM. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med. 1999;160:1009-14.
38. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003;167:1225-31.
39. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med. 2001;164:840-6.
40. Rybicki BA, Maliarik J, Poisson LM, Sheffer R, Chen KM, Major M, et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med. 2003;167:444-9.
41. Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, et al. Sarcoidosis: social predictors of severity at presentation. Eur Respir J. 2004;24:601-8.
42. Olden K, White SL. Health-related disparities: influence of environmental factors. Med Clin North Am. 2005;89:721-38.
43. Semenzato G, Bortoli M, Brunetta E, Agostini C. Immunology and pathophysiology of sarcoidosis. Eur Respir Mon. 2005;32:49-63.
44. Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel. A 27-year historical prospective study, 1975-2001. Chest. 2004;126:1431-8.
45. Barnard J, Cecile R, Newman L, Canner M, Martyny J, McCammon C, et al. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (ACCESS). J Occup Environ Med. 2005;47:226-34.
46. Kajdasz DK, Judson MA, Mohr LC, Lackland DT. Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. Am J Epidemiol. 1999;150:271-8.
47. Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, Maliarik MJ, et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest. 2003;123:1527-35.
48. Brown ST, Brett I, Almenoff PL, Lesser M, Terrin M, Teirstein AS. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest. 2003;123:413-7.
49. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet. 1992;339:1012-5.
50. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti JP, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis. 1992;145:1142-8.
51. Fite E, Fernández-Figueras MT, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration. 2006;73:20-6.
52. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201:755-67.
53. Padilla ML, Schilero GJ, Teirstein AS. Donor-acquired sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:18-24.
54. Müller CBJ. Sarcoidosis recurrence following lung transplantation. Transplantation. 1996;16:1117-9.
55. Ikonomopoulos JA, Gorgoulis VG, Kastrinakis NG, Galanos AA, Karameris A, Kittas C. Experimental inoculation of laboratory animals with samples collected from sarcoidal patients and molecular diagnosis evaluation of the results. In Vivo. 2000;14:761-5.
56. Vidal S, De la Horra C, Martín J, Montes-Cano MA, Rodríguez E, Respaldiza N, et al. Pneumocystis jiroveci colonisation in patients with interstitial lung disease. Clin Microbiol Infect. 2006;12:231-5.
57. Gazouli M, Ikonomopoulos J, Koundourakis A, Bartos M, Pavlik I, Overduin P, et al. Characterization of Mycobacterium tuberculosis complex isolates from Greek patients with sarcoidosis by spoligotyping. J Clin Microbol. 2005;43:4858-61.
58. McGrath DS, Daniil Z, Foley P, Du Bois JL, Lympany PA, Cullinan P, et al. Epidemiology of familial sarcoidosis in the UK. Thorax. 2000;55:751-4.
59. Harrington D, Major M, Popovich J, Maliarik M, Iannuzzi M. Familial sarcoidosis: analysis of 61 families. Am Rev Respir Dis. 1993;147:A91.
60. Thomeer M, Demedts M, Wuyts W. Epidemiology of sarcoidosis. Eur Respir Mon. 2005;32:13-22.
61. Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J, Chase GA, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol. 2001;153:188-93.
62. Pérez Arellano JL. Lavado broncoalveolar en la enfermedad pulmonar intersticial. Últimas noticias. Arch Bronconeumol. 2002;38:57-9.
63. Çelik G, Sen E, Ülger AF, Özdemir-Kumbasar Ö, Alper D, Elhan AH, et al. Antígenos leucocitarios humanos A y B en pacientes turcos con sarcoidosis. Arch Bronconeumol. 2004;40:449-52.
64. Du Bois RM, Beirne PA, Anevlavis SE. Genetics of sarcoidosis. Eur Respir Mon. 2005;32:64-81.
65. Rossman MD, Thompson BT, Frederik M, Maliarik M, Iannuzzi MC, Rybicki BA, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in Blacks and Whites. Am J Hum Genet. 2003;73:720-35.
66. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC and the ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet. 2005;77:491-9.
67. Rybicki BA, Hirst K, Iyengar SK, Barnard JG, Judson MA, Rose CS, et al. A sarcoidosis genetic linkage consortium: the Sarcoidosis Genetic Analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:83-6.
68. Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF, et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 2005;6:509-18.